Status:

COMPLETED

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Alzheimer Disease

Eligibility:

All Genders

60-85 years

Phase:

PHASE1

Brief Summary

Impaired verbal communication is a cardinal symptom of Alzheimer Disease (AD) and the source of enormous distress and disability. Effective therapies for this deficit are lacking. In light of the emer...

Detailed Description

TMS is a technique by which a brief electrical current is induced in brain tissue causing a brief suppression of the excitability of the underlying tissue; the technique, which was introduced in the 1...

Eligibility Criteria

Inclusion

  • A diagnosis of mild-moderate AD as defined by the National Institute of Aging - Alzheimer's Disease and Related Disorders Association criteria
  • Mild-moderate cognitive impairment, indicated by Mini-Mental Status Exam (MMSE) scores between 23 and 15 inclusive
  • Must be right handed as defined by the Edinburgh Handedness Inventory
  • Must be a native English speaker
  • Must be able to understand the nature of the study, and give informed consent

Exclusion

  • History of stroke
  • History of seizure
  • History of any other significant neurologic disease (e.g., ALS)
  • Significant depression as defined by the Geriatric Depression Scale.
  • Any significant medical disorder that, in the view of the investigators, could threaten the subject's ability to complete the study (e.g., cancer, significant cardiac disease)
  • Any contraindications to TMS, including uncontrolled seizures, previous brain surgery, and history of tinnitus

Key Trial Info

Start Date :

February 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2024

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT04482179

Start Date

February 19 2020

End Date

August 31 2024

Last Update

September 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease | DecenTrialz